Drugs of Abuse Testing

Home Clinical Laboratory Diagnostic Products and Solutions Chemistry Drugs of Abuse Testing

Chemistry

A Growing Global Issue

The amount of drug usage is increasing around the globe ³, and with it grows the number
of illicit drug use and drug-abuse-related deaths.⁵

Menu Offering

Expanded Drugs of Abuse:
6- acetylmorphine* Amphetamines* Barbiturates* Barbiturate Serum Tox* Benzodiazepine* Benzodiazepine Serum Tox* Buprenorphine* Cannabinoid* Cocaine Metabolite* Ecstasy* Ethyl Alcohol*		Fentanyl Hydrocodone Ketamine** LSD* Methadone* Methaqualone* Opiate* Phencyclidine* Propoxyphene* Tricyclics Serum Tox* Download brochure >
manufactured by Siemens , *manufactured by Lin-Zhi

Introducing Three New Esoteric Drugs of Abuse Testing Assays

Intended for the qualitative or semi-quantitative determination of norfentanyl in human urine. It’s the only assay that can measure norfentanyl up to 100% cross-reactivity at a low cutoff of 5 ng/mL

Intended for the qualitative or semi-quantitative determination of hydrocodone in human urine at a cutoff of 300 ng/mL.

Intended for the qualitative or semi-quantitative determination of norketamine in human urine at the cutoff values of 50ng/mL.

Why is Drug Testing Important? With new substances emerging and global drug abuse rising, accurate drug testing is essential.

BROCHURE
The Global Drug Market Grows Complex as New Substances Emerge

The lines between legal and illegal drug markets are becoming increasingly blurred. Learn more about the need for laboratory adaptation and our extensive drug abuse test menu.

Download

BLOG
The Rising Problem of Drug Abuse and the Need for Detection that Matters

Drug abuse around the world is on the rise and there is a demand for robust drug detection and monitoring solutions throughout institutions globally.

Read blog

Address a Greater Demand

Meet the testing demands for drugs-of-abuse detection and therapeutic drug monitoring in your laboratory with a comprehensive menu of assays.

Explore now

Scalable Chemistry Solutions to Meet Any Workload

Consolidate testing and experience the flexibility to choose the right instrument and reagent combination to suit your laboratory's on-site requirements. Our comprehensive therapeutic drug monitoring and drugs-of-abuse menus run on the following Beckman Coulter Clinical Chemistry Analyzers:

Would you like more information on our drug of abuse testing solutions?
Let’s connect.

References:
Products listed may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information
1. Complications | ADA. (2021). American Diabetes Association. https://www.diabetes.org/diabetes/complications
2. IDF Diabetes Atlas 9th edition 2019. (2019). International Diabetes Federation. https://diabetesatlas.org/en/
3. Worldwide toll of diabetes. (2019). International Diabetes Federation. https://diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html
4. Individual, social and economic impact. (2019). International Diabetes Federation. https://diabetesatlas.org/en/sections/individual-social-and-economic-impact.html#:~:text=Diabetes increases the risk of,one death every eight seconds.
5. HbA1c (Hemoglobin A1c) Instructions for Use (IFU). B00389. Beckman Coulter, Inc. February 2021.
6. HbA1c (Hemoglobin A1c) Advanced Instructions for Use (IFU). B93009. Beckman Coulter, Inc. February 2021.
7. Access C-Peptide Instructions for Use (IFU). C33451. Beckman Coulter, Inc. February 2021.
8. Fructosamine Liquid Instructions for Use (IFU). 1735001. Beckman Coulter, Inc. February 2021.
9. When Should You Order a Serum Fructosamine Level for a Diabetic Patient? – Clinical Correlations. (2007, March 14). Clinical Correlations. https://www.clinicalcorrelations.org/2007/03/14/when-should-you-order-a-serum-fructosamine-level-for-a-diabetic-patient/#:~:text=Fructosamine testing has been available,diabetics control their blood sugar.&text=The American Diabetes Association (ADA,A1C cannot be reliably measured.
10. This product is not available in the United States at this time. Please contact your Beckman Coulter sales representative or distributor for more information.
11. Editorial Staff. (2019, August 8). The Best Tests to Diagnose Diabetes. UC Berkeley School of Public Health: Health and Wellness Alerts. https://www.healthandwellnessalerts.berkeley.edu/topics/diabetes/the-best-tests-to-diagnose-diabetes/#:~:text=Fasting plasma glucose test measures,initial diagnostic method for decades.
12. Editorial Staff. (2019, August 8). The Best Tests to Diagnose Diabetes. UC Berkeley School of Public Health: Health and Wellness Alerts. https://www.healthandwellnessalerts.berkeley.edu/topics/diabetes/the-best-tests-to-diagnose-diabetes/#:~:text=Fasting plasma glucose test measures,initial diagnostic method for decades.
13. Urine Albumin Screening and Monitoring in Type 2 DM. (2009). IHS Division of Diabetes Treatment and Prevention. https://www.ihs.gov/sites/diabetes/themes/responsive2017/display_objects/documents/algorithms/DM_algorithm_Urine_Alb_508c.pdf
14. Urine/CSF Albumin Instructions for Use (IFU). B38858. B46435. Beckman Coulter, Inc. February 2021.
15. Diabetes - Symptoms and causes. (2020, October 30). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444
16. Sortso, C., Komkova, A., Sandbæk, A., Griffin, S. J., Emneus, M., Lauritzen, T., & Simmons, R. K. (2018). Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Springermedizin.De. https://www.springermedizin.de/effect-of-screening-for-type-2-diabetes-on-healthcare-costs-a-re/15542004?fulltextView=true
17. Diabetes - Symptoms and causes. (2020b, October 30). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444
18. Global report on diabetes. (2016). World Health Organization. https://www.who.int/publications/i/item/9789241565257/
19. IDF Diabetes Atlas, Eighth Edition, 2017.
20. International Expert Committee, 2009. International Expert Committee report on the Role of the A1C assay in the Diagnosis of Diabetes. Diabetes Care, 32(7), pp. 1327-1334.
21. NGSP: HbA1c Assay Interferences. (2020, August). NGSP. http://www.ngsp.org/interf.asp
22. Diabetes Care 2018: 41 (Supplement 1): S13-S27. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes, 2018.
23. The WHO Logo and Emblem. (2021). World Health Organization. https://www.who.int/about/who-we-are/publishing-policies/logo
24. Home | ADA. (2021). American Diabetes Association (ADA). https://www.diabetes.org/
25. American Diabetes Association, 2010. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, Volume 33, pp. 62-69.
26. International Expert Committee, 2009. International Expert Committee report on the Role of the A1C assay in the Diagnosis of Diabetes. Diabetes Care, 32(7), pp. 1327-1334.
27. WHO, n.d. World Health Organization (WHO). [Online] Available at: http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/[Accessed 01 May 2017].

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Choose your country/region and language

Country or Region

Language

Drugs of Abuse Testing

A Growing Global Issue

The amount of drug usage is increasing around the globe 3, and with it grows the number of illicit drug use and drug-abuse-related deaths.5

Menu Offering

Expanded Drugs of Abuse:

Introducing Three New Esoteric Drugs of Abuse Testing Assays

Why is Drug Testing Important? With new substances emerging and global drug abuse rising, accurate drug testing is essential.

BROCHURE The Global Drug Market Grows Complex as New Substances Emerge

BLOG The Rising Problem of Drug Abuse and the Need for Detection that Matters

Address a Greater Demand

Scalable Chemistry Solutions to Meet Any Workload

AU480

AU680

DxC 700 AU

AU5800 Series

Would you like more information on our drug of abuse testing solutions? Let’s connect.

The amount of drug usage is increasing around the globe ³, and with it grows the number
of illicit drug use and drug-abuse-related deaths.⁵

BROCHURE
The Global Drug Market Grows Complex as New Substances Emerge

BLOG
The Rising Problem of Drug Abuse and the Need for Detection that Matters

Would you like more information on our drug of abuse testing solutions?
Let’s connect.